The authors also suggest that activation of NLRP3 enhances Alzheimer's disease and may be involved in synaptic dysfunction, cognitive impairment, and the restriction of microglial clearance functions (Heneka et al., 2013). Here, NLRP3 is linked to early-onset autosomal dominant Alzheimer disease.